Blocking platelet CLEC-2 signalling by inducing a selective platelet CLEC-2 deficiency or a podoplanin blockade resulted in a reduction in hepatocellular damage and transaminase release through increased hepatic neutrophil recruitment. The gene discussed is PDPN; the disease is hyperinsulinemic hypoglycemia, familial, 4.